Dáil Éireann Debate, Thursday - 8 September 2022
1698. Deputy Michael Lowry asked the Minister for Health the reason that Glucogel, formerly known as Hypostop, has been removed from the long-term illness card and medical card for persons with diabetes (details supplied); and if he will make a statement on the matter. [42704/22]
View answerThe Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines and medical items, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013.
The HSE have advised that Glucogel (Hypostop) has never been on the formal Reimbursement List.
However, due to the nature of the product for the management of hypoglycaemia, reimbursement support is available for people with Diabetes Mellitus under the Long Term Illness scheme.
